CD4 and neoplasm: They develop tumors with heterogeneous phenotypes, regarding the expression of CD4 and CD8 markers, including some in which peripheral tumor T cells display a prevalent CD4−CD8− or CD4+CD8− or CD4−CD8+ phenotype (9).